Yifan Xinfu Pharmaceutical Co Ltd (002019) — Cash Flow-to-Debt Ratio
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥40.18 Million could theoretically repay 0% of its total liabilities (CN¥4.40 Billion) in one year. Explore 002019 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yifan Xinfu Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Yifan Xinfu Pharmaceutical Co Ltd across 23 annual periods. Also explore Yifan Xinfu Pharmaceutical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Yifan Xinfu Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 002019 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | CN¥458.37 Million | CN¥4.13 Billion | ▼ -33.2% |
| 2024 | 0.17x | CN¥640.73 Million | CN¥3.86 Billion | ▲ +54.5% |
| 2023 | 0.11x | CN¥348.58 Million | CN¥3.24 Billion | ▼ -22.7% |
| 2022 | 0.14x | CN¥472.07 Million | CN¥3.40 Billion | ▲ +56.4% |
| 2021 | 0.09x | CN¥301.23 Million | CN¥3.39 Billion | ▼ -76.0% |
| 2020 | 0.37x | CN¥1.11 Billion | CN¥2.99 Billion | ▲ +28.4% |
| 2019 | 0.29x | CN¥937.24 Million | CN¥3.24 Billion | ▼ -28.8% |
| 2018 | 0.41x | CN¥1.17 Billion | CN¥2.89 Billion | ▼ -28.9% |
| 2017 | 0.57x | CN¥1.13 Billion | CN¥1.99 Billion | ▲ +105.5% |
| 2016 | 0.28x | CN¥855.85 Million | CN¥3.08 Billion | ▲ +15.1% |
| 2015 | 0.24x | CN¥401.96 Million | CN¥1.67 Billion | ▲ +36.6% |
| 2014 | 0.18x | CN¥139.74 Million | CN¥791.21 Million | ▲ +48.3% |
| 2013 | 0.12x | CN¥34.32 Million | CN¥288.20 Million | ▲ +131.4% |
| 2012 | 0.05x | CN¥29.88 Million | CN¥580.73 Million | ▲ +167.9% |
| 2011 | -0.08x | CN¥-52.82 Million | CN¥696.73 Million | ▼ -11.6% |
| 2010 | -0.07x | CN¥-33.82 Million | CN¥497.79 Million | ▼ -126.4% |
| 2009 | 0.26x | CN¥58.61 Million | CN¥227.31 Million | ▼ -11.7% |
| 2008 | 0.29x | CN¥83.31 Million | CN¥285.39 Million | ▼ -60.6% |
| 2007 | 0.74x | CN¥248.71 Million | CN¥335.87 Million | ▲ +508.2% |
| 2006 | 0.12x | CN¥32.62 Million | CN¥267.92 Million | ▼ -1.1% |
| 2005 | 0.12x | CN¥24.12 Million | CN¥196.02 Million | ▼ -82.1% |
| 2004 | 0.69x | CN¥33.59 Million | CN¥48.72 Million | ▲ +470.5% |
| 2003 | 0.12x | CN¥12.65 Million | CN¥104.73 Million | — |